Researchers have linked the popular cancer treatment drug, Tasigna (generic name, nilotinib), manufactured by Novartis to irreversible atherosclerosis, coronary artery disease, and peripheral arterial disease (PAD), which can be deadly. This condition causes plaque...
Researchers continue to link the popular cancer treatment drug, Tasigna to atherosclerosis. However, the manufacturer of the drug, Novartis still continues to deny the connection. In fact, they won’t update the label to warn American consumers even though they...
Recent Comments